Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @NavitorPharma
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NavitorPharma
-
Congratulations to SAB member Michael Hall and Navitor Scientific Founder,
@DMSabatini, on#WorldCancerDay
for receiving the #SjöbergPrize 2020 for the discovery of mTOR and its role in the control of cell metabolism and growth, laying the foundation for new cancer treatments.https://twitter.com/vetenskapsakad/status/1224586846333698050 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to
@DMSabatini, our scientific founder, on receiving@BBVA Foundation Frontiers of Knowledge Award in Biomedicine for the discovery of mTOR.https://twitter.com/DMSabatini/status/1219935655989477376 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Does location matter?
@NavitorPharma CEO, Tom Hughes, moderated a panel yesterday@LeadingBiotech’s#EastWestCEO forum on emerging biotech clusters in the US.pic.twitter.com/vLerW2oSow
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking forward to a busy few days at
#JPM20 and connecting with friends and colleagues. See you in San Francisco!pic.twitter.com/LdHPzivimb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We want to thank retiring President and Chief Scientific Officer
@GVlasuk for his leadership and wisdom during his tenure at Navitor and express our gratitude for his continued guidance as a board member. CEO, Tom Hughes, will now be@Navitor’s President and CEO.pic.twitter.com/qgH2KBrwEi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@NavitorPharma CEO, Tom Hughes, gave a poster presentation today at#ACNP showing how mTORC1 activation is a new mechanistic concept for antidepressants based on work with ketamine and other agents.#depression. Read more here: http://bit.ly/2XjPvhJHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
mTORC1 Activator NV-5138 shows rapid efficacy signals and favorable tolerability in treatment-resistant
#depression. Learn more in our poster presented at#ACNP today. https://bit.ly/358mOE7Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Excited to be presenting data next week at
#ACNP from our Phase 1 program showing antidepressant effects and biomarker impact of NV-5138, a direct activator of mTORC1. Learn more here: https://bit.ly/34ToUrv#depressionHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Always exciting to tell the Navitor story and how we are activating mTORC1 in the brain, particularly those regions associated with learning, memory formation and recall, and control of mood.
#PJCHCC19pic.twitter.com/rqRdsKvADT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tom Hughes, CEO
@NavitorPharma during the Stifel 2019 Healthcare Conference discussing the company’s history, pipeline and novel approach to treat#depression with clinical compound NV-5138, the first selective oral mTORC1 activator.pic.twitter.com/BknJbVnrQ5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Excellent Neuroscience Spotlight Session
@CNSSummit.@Navitor CMO Randy Owen presented data on Navitor’s NV-5138, a direct mTORC1 activator, for the treatment of depression.pic.twitter.com/adHejbqwsL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Check out our poster
@Neurosci2019 presented today by Dr. Emilie Giaime@NavitorPharma. For more information on clinical compound NV-5138, the first selective oral mTORC1 activator for#depression, our full poster can be found here: http://bit.ly/2Pcuv7e#SfN19pic.twitter.com/l7r67dDSgm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Don't miss our poster session tomorrow
@Neurosci2019 where Dr. Emilie Giaime will answer questions on the@Navitorpharma clinical compound NV-5138, the first selective oral mTORC1 activator for#depression. Abstract here: https://bit.ly/2By7AeD#SfN19Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Proud to announce initial P1 results for NV-5138! Data show the rapid antidepressant effects and biomarker impact of our direct activator of mTORC1, and lay the groundwork for further development in
#depression. Read more here: http://bit.ly/2kbNgKMHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks
#BTIG for hosting an informative CNS Therapeutics panel today. Our CEO Tom Hughes joined Dr. Robert Ostroff, Axsome Therapeutics and Intra-Cellular Therapies to discuss the ever-changing treatment landscape.pic.twitter.com/GWXadxZvDS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are delighted to welcome Randy Owen, M.D. as our Chief Medical Officer! In this newly created position, Dr. Owen will lead clinical development of our pipeline of mTORC1-targeted therapeutics, including NV-5138 for treatment-resistant depression. http://bit.ly/2YUnqtM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@CellChemBiol paper details discovery of specific inhibitors of glucose transporter family exemplified by GLUT1-this comes from our efforts to discover novel selective modulators mTORC1 & expanded our unique understanding of this central metabolic pathwayhttp://bit.ly/2XoWmWcHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you
#BIO2019@UnityBiotech @resTORbio and@LauraDeming for an informative panel yesterday. Looking forward to continued innovations across the space as we collectively work to increase human healthspan.pic.twitter.com/DdlyM6DiTN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our CEO Tom Hughes is getting ready to discuss how we are translating our mTORC1 platform to bring forward new therapies to improve human health at the
#BIO2019 panel “Anti-Aging Therapies: Taking Action to Increase the Human Healthspan” http://bit.ly/2VZt5SbHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
See you next week at
#BIO2019! Can’t wait to join@UnityBiotech@resTORbio_Inc and@LauraDeming to discuss Anti-Aging Therapies: Taking Action to Increase the Human Healthspan on Tues. June 4th at 3:15pm. http://bit.ly/2VZt5SbHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.